World Rural Health Conference
Home Print this page Email this page Small font size Default font size Increase font size
Users Online: 2187
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others


Drug-induced hepatitis and the risk factors for liver injury in pulmonary tuberculosis patients

Gaude Gajanan S, Chaudhury Alisha, Hattiholi Jyothi

Year : 2015| Volume: 4| Issue : 2 | Page no: 238-243

   This article has been cited by
1 Heavy Consumption of Alcohol is Not Associated With Worse Outcomes in Patients With Idiosyncratic Drug-induced Liver Injury Compared to Non-Drinkers
Lara Dakhoul,Marwan Ghabril,Jiezhun Gu,Victor Navarro,Naga Chalasani,Jose Serrano
Clinical Gastroenterology and Hepatology. 2018;
[Pubmed]  [Google Scholar] [DOI]
2 Extrapulmonary tuberculosis: a debilitating and often neglected public health problem
Sudeep Adhikari,Buddha Basnyat
BMJ Case Reports. 2018; 11(1): e226098
[Pubmed]  [Google Scholar] [DOI]
3 Antibiotic complications during the treatment of Mycobacterium ulcerans disease in Australian patients
Daniel P. OBrien,Deborah Friedman,Andrew Hughes,Aaron Walton,Eugene Athan
Internal Medicine Journal. 2017; 47(9): 1011
[Pubmed]  [Google Scholar] [DOI]
4 Drug-induced liver injury from antituberculous treatment: a retrospective study from a large TB centre in the UK
Aula Abbara,Sarah Chitty,Jennifer K. Roe,Rohma Ghani,Simon M. Collin,Andrew Ritchie,Onn Min Kon,John Dzvova,Harriet Davidson,Thomas E. Edwards,Charlotte Hateley,Matthew Routledge,Jim Buckley,Robert N. Davidson,Laurence John
BMC Infectious Diseases. 2017; 17(1)
[Pubmed]  [Google Scholar] [DOI]
5 Substantially Higher and Earlier Occurrence of Anti-Tuberculosis Drug-Related Adverse Reactions in HIV Coinfected Tuberculosis Patients: A Matched-Cohort Study
Takashi Matono,Takeshi Nishijima,Katsuji Teruya,Eriko Morino,Jin Takasaki,Hiroyuki Gatanaga,Yoshimi Kikuchi,Mitsuo Kaku,Shinichi Oka
AIDS Patient Care and STDs. 2017; 31(11): 455
[Pubmed]  [Google Scholar] [DOI]
6 Drug Hepatotoxicity
Jonathan G. Stine,Naga P. Chalasani
Clinics in Liver Disease. 2017; 21(1): 103
[Pubmed]  [Google Scholar] [DOI]
7 MIR196A2rs11614913 C>T polymorphism correlates with an increased risk of hepatopulmonary syndrome in liver cirrhosis: a case-control study in China
Hai-Yong Chen,Yao-Min Chen,Jian Wu,Fu-Chun Yang,Zhen Lv,Xiao-Feng Xu,Shu-Sen Zheng,Sang-Sang Liao,Yi-Hui Luo
Hepatology Research. 2016;
[Pubmed]  [Google Scholar] [DOI]
8 Drug-induced liver injury: Is chronic liver disease a risk factor and a clinical issue?
Rolf Teschke,Gaby Danan
Expert Opinion on Drug Metabolism & Toxicology. 2016; : 1
[Pubmed]  [Google Scholar] [DOI]
9 A Severe Hepatotoxicity by Antituberculosis Drug, and its Recovery in Oriental Hospital
Chang-Gue Son
Journal of Korean Medicine. 2016; 37(2): 119
[Pubmed]  [Google Scholar] [DOI]
10 Diallyl trisulfide protects the liver against hepatotoxicity induced by isoniazid and rifampin in mice by reducing oxidative stress and activating Kupffer cells
Yilin Yang,Lulu Jiang,Shuo Wang,Tao Zeng,Keqin Xie
Toxicol. Res.. 2016;
[Pubmed]  [Google Scholar] [DOI]
11 Encapsulation of zinc-rifampicin complex into transferrin-conjugated silver quantum-dots improves its antimycobacterial activity and stability and facilitates drug delivery into macrophages
Rashmirekha Pati,Rojalin Sahu,Jagannath Panda,Avinash Sonawane
Scientific Reports. 2016; 6: 24184
[Pubmed]  [Google Scholar] [DOI]


Read this article